Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2003 10
2004 5
2005 9
2006 15
2007 3
2008 5
2009 7
2010 16
2011 8
2012 14
2013 15
2014 10
2015 14
2016 14
2017 4
2018 6
2019 4
2020 1
2021 3
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery.
Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, Longo M, Salazar A, Dalton W, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Metz TD, Rood K, Rouse DJ, Bailit JL, Grobman WA, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Pacheco LD, et al. N Engl J Med. 2023 Apr 13;388(15):1365-1375. doi: 10.1056/NEJMoa2207419. N Engl J Med. 2023. PMID: 37043652 Free PMC article. Clinical Trial.
CONCLUSIONS: Prophylactic use of tranexamic acid during cesarean delivery did not lead to a significantly lower risk of a composite outcome of maternal death or blood transfusion than placebo. (Funded by the Eunice Kennedy Shriver National Institute of Child Heal …
CONCLUSIONS: Prophylactic use of tranexamic acid during cesarean delivery did not lead to a significantly lower risk of a composite outcome …
Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.
Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Grobman WA, et al. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566. N Engl J Med. 2018. PMID: 30089070 Free PMC article. Clinical Trial.
CONCLUSIONS: Induction of labor at 39 weeks in low-risk nulliparous women did not result in a significantly lower frequency of a composite adverse perinatal outcome, but it did result in a significantly lower frequency of cesarean delivery. (Funded by the Eunice Kennedy Shriver …
CONCLUSIONS: Induction of labor at 39 weeks in low-risk nulliparous women did not result in a significantly lower frequency of a composite a …
Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.
Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG, Reddy UM, Wapner RJ, Thorp JM Jr, Saade G, Tita AT, Rouse DJ, Sibai B, Iams JD, Mercer BM, Tolosa J, Caritis SN, VanDorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Casey BM, et al. N Engl J Med. 2017 Mar 2;376(9):815-825. doi: 10.1056/NEJMoa1606205. N Engl J Med. 2017. PMID: 28249134 Free PMC article. Clinical Trial.
CONCLUSIONS: Treatment for subclinical hypothyroidism or hypothyroxinemia beginning between 8 and 20 weeks of gestation did not result in significantly better cognitive outcomes in children through 5 years of age than no treatment for those conditions. (Funded by the Eunice Kenne …
CONCLUSIONS: Treatment for subclinical hypothyroidism or hypothyroxinemia beginning between 8 and 20 weeks of gestation did not result in si …
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
Hughes BL, Clifton RG, Rouse DJ, Saade GR, Dinsmoor MJ, Reddy UM, Pass R, Allard D, Mallett G, Fette LM, Gyamfi-Bannerman C, Varner MW, Goodnight WH, Tita ATN, Costantine MM, Swamy GK, Gibbs RS, Chien EK, Chauhan SP, El-Sayed YY, Casey BM, Parry S, Simhan HN, Napolitano PG, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Hughes BL, et al. N Engl J Med. 2021 Jul 29;385(5):436-444. doi: 10.1056/NEJMoa1913569. N Engl J Med. 2021. PMID: 34320288 Free PMC article. Clinical Trial.
CONCLUSIONS: Among pregnant women, administration of CMV hyperimmune globulin starting before 24 weeks' gestation did not result in a lower incidence of a composite of congenital CMV infection or perinatal death than placebo. (Funded by the Eunice Kennedy Shriver National …
CONCLUSIONS: Among pregnant women, administration of CMV hyperimmune globulin starting before 24 weeks' gestation did not result in a lower …
Maternal morbidity associated with multiple repeat cesarean deliveries.
Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Silver RM, et al. Obstet Gynecol. 2006 Jun;107(6):1226-32. doi: 10.1097/01.AOG.0000219750.79480.84. Obstet Gynecol. 2006. PMID: 16738145
Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity.
Grobman WA, Sandoval G, Rice MM, Bailit JL, Chauhan SP, Costantine MM, Gyamfi-Bannerman C, Metz TD, Parry S, Rouse DJ, Saade GR, Simhan HN, Thorp JM Jr, Tita ATN, Longo M, Landon MB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Grobman WA, et al. Am J Obstet Gynecol. 2021 Dec;225(6):664.e1-664.e7. doi: 10.1016/j.ajog.2021.05.021. Epub 2021 May 24. Am J Obstet Gynecol. 2021. PMID: 34043983 Free PMC article.
However, concern has been raised that this tool includes the socially constructed variables of race and ethnicity. OBJECTIVE: This study aimed to develop an accurate tool to predict vaginal birth after cesarean delivery, using data easily obtainable early in pregnancy, wit …
However, concern has been raised that this tool includes the socially constructed variables of race and ethnicity. OBJECTIVE: This st …
A multicenter, randomized trial of treatment for mild gestational diabetes.
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Landon MB, et al. N Engl J Med. 2009 Oct 1;361(14):1339-48. doi: 10.1056/NEJMoa0902430. N Engl J Med. 2009. PMID: 19797280 Free PMC article. Clinical Trial.
What we have learned about the design of randomized trials in pregnancy.
Thom EA, Rice MM, Saade GR, Reddy UM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Thom EA, et al. Semin Perinatol. 2016 Aug;40(5):328-34. doi: 10.1053/j.semperi.2016.03.011. Epub 2016 Jun 22. Semin Perinatol. 2016. PMID: 27344190 Free PMC article. Review.
For nearly 30 years the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network has been conducting randomized trials in pregnant women, many of which have changed clinical practice. …
For nearly 30 years the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Materna …
Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers.
Battarbee AN, Mele L, Landon MB, Varner MW, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Thorp JM, Chien EK, Saade G, Peaceman AM, Blackwell SC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Battarbee AN, et al. Am J Perinatol. 2023 Jun 29:10.1055/a-2096-0443. doi: 10.1055/a-2096-0443. Online ahead of print. Am J Perinatol. 2023. PMID: 37201538
What we have learned about best practices for recruitment and retention in multicenter pregnancy studies.
Salazar A, Tolivaisa S, Allard D, Bishop TS, Bousleiman S, Clark K, Dalton W, Harris S, Hale K, Hill K, Johnson F, Mallett G, Moseley L, Ortiz F, Willson C, Thom EA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Salazar A, et al. Semin Perinatol. 2016 Aug;40(5):321-7. doi: 10.1053/j.semperi.2016.03.010. Epub 2016 May 9. Semin Perinatol. 2016. PMID: 27174555 Free PMC article. Review.
For 30 years, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network has had significant impact on clinical practice in obstetrics. ...
For 30 years, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Feta …
157 results